Cite
Butyrylcholinesterase Levels on Admission Predict Severity and 12-Month Mortality in Hospitalized AIDS Patients.
MLA
Xu, Lijun, et al. “Butyrylcholinesterase Levels on Admission Predict Severity and 12-Month Mortality in Hospitalized AIDS Patients.” Mediators of Inflammation, Mar. 2018, pp. 1–10. EBSCOhost, https://doi.org/10.1155/2018/5201652.
APA
Xu, L., Zhu, B., Huang, Y., Yang, Z., Sun, J., Xu, Y., Zheng, J., Kinloch, S., Yin, M. T., Weng, H., & Wu, N. (2018). Butyrylcholinesterase Levels on Admission Predict Severity and 12-Month Mortality in Hospitalized AIDS Patients. Mediators of Inflammation, 1–10. https://doi.org/10.1155/2018/5201652
Chicago
Xu, Lijun, Biao Zhu, Ying Huang, Zongxing Yang, Jia Sun, Yan Xu, Jinlei Zheng, et al. 2018. “Butyrylcholinesterase Levels on Admission Predict Severity and 12-Month Mortality in Hospitalized AIDS Patients.” Mediators of Inflammation, March, 1–10. doi:10.1155/2018/5201652.